Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Fabrication, Characterization and Wound-Healing Properties of Core-Shell SF@chitosan/ZnO/ Astragalus Arbusculinus Gum Nanofibers.

Amiri Z., Molavi AM., Amani A., Moqadam KH., Vatanchian M., Hashemi SA.

Animal Study on Diabetic Foot, Chronic Wound, published in Nanomedicine (Lond) (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Nanomedicine (Lond) (2024)
Country
England
Reported sample size
—
Source database
PubMed
PMID
38293919
DOI
10.2217/nnm-2023-0311
Citations
7

Abstract (original English)

Aim Silk fibroin/chitosan/ZnO/ Astragalus arbusculinus (Ast) gum fibrous scaffolds along with adipose-derived mesenchymal stem cells (ADSCs) were investigated for accelerating diabetic wound healing. Methods Scaffolds with a core-shell structure and different compositions were synthesized using the electrospinning method. Biological in vitro investigations included antibacterial testing, cell viability analysis and cell attachment evaluation. In vivo experiments, including the chicken chorioallantoic membrane (CAM) test, were conducted to assess wound-healing efficacy and histopathological changes. Results The incorporation of Ast to the silk fibroin@ chitosan/ZnO scaffold improved wound healing in diabetic mice. In addition, seeding of ADSCs on the scaffold accelerated wound healing. Conclusion These findings suggest that the designed scaffold can be useful for skin regeneration applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
ChitosanAnimalsWound HealingFibroinsNanofibersMiceZinc OxideMesenchymal Stem CellsTissue ScaffoldsCell Survival

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research